# Meibomian Gland Probing in the Sub-Acute Phase of Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

> **NCT05145959** · NA · UNKNOWN · sponsor: **Massachusetts Eye and Ear Infirmary** · enrollment: 30 (estimated)

## Conditions studied

- Stevens-Johnson Syndrome
- Toxic Epidermal Necrolyses
- Ocular Surface Disease
- Meibomitis
- Meibomian Gland Dysfunction
- Dry Eye

## Interventions

- **DEVICE:** Maskin Probe

## Key facts

- **NCT ID:** NCT05145959
- **Lead sponsor:** Massachusetts Eye and Ear Infirmary
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2024-03-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2021-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05145959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05145959, "Meibomian Gland Probing in the Sub-Acute Phase of Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05145959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*